Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
Kestra Medical Technologies develops advanced wearable cardiac devices and digital health solutions for cardiovascular care providers.
Kestra Medical Technologies develops advanced wearable cardiac devices and digital health solutions for cardiovascular care providers.
Kestra Medical Technologies, Ltd. (KMTS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
KIRKLAND, Wash., April 22, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
KIRKLAND, Wash., April 09, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Director Raymond W. Cohen acquired 10,000 shares for a transaction value of approximately $200,000 on March 26, 2026.
KIRKLAND, Wash., March 25, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a finalist in the “Deal of the Year” category for the 2026 GeekWire Awards. Now in its 15th year, the annual awards recognize companies and leaders shaping the Pacific Northwest technology ecosystem, where Kestra continues to expand its presence.
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS - Get Free Report) insider Brian Daniel Webster sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $20.27, for a total transaction of $304,050.00. Following the sale, the insider directly owned 364,786 shares of
Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript
KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the third quarter fiscal 2026, which ended January 31, 2026.
KIRKLAND, Wash., March 03, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it will report third quarter fiscal 2026 financial results on Tuesday, March 17. Management will host a corresponding conference call at 4:30 p.m. Eastern Time.
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS - Get Free Report) insider Brian Daniel Webster sold 15,000 shares of the firm's stock in a transaction dated Thursday, January 15th. The shares were sold at an average price of $22.80, for a total value of $342,000.00. Following the sale, the insider owned 394,786 shares in the company, valued
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS - Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 2,413,847 shares, an increase of 21.5% from the December 15th total of 1,986,266 shares. Currently, 4.3% of the shares of the company